NEW YORK (Reuters Health) Aug 01 -
Statin users did not have a lower
rate of biochemical recurrence after radical prostatectomy in a recent
study.
"Prostate cancer can be a very aggressive
disease, and we are all looking for a golden bullet to stop it in its
tracks," Dr. Alon Y. Mass from New York University School of Medicine in
New York City told Reuters Health by email.
"We entered this study
being hopeful that we may be able to isolate a viable therapy to combat
the progression of prostate cancer after prostatectomy. Unfortunately,
statins don't seem to be the answer."
Read the full Reuteurs Health report via Medscape Today
(Free sign-up may be required)
